Bortezomib
NDC product · U.S. Food and Drug Administration (openFDA) · United States
-
Product NDC
51817-586 -
Package NDC
51817-586-01 -
Application number
ANDA208392 -
SPL ID
de0c8157-9e0e-4964-e053-2995a90a1259 -
SPL set ID
191d231a-1fbd-4a65-9d33-d5dc03bac381 -
UNII
69G8BD63PP -
RxCUI
402243
What the source publishes
- Labeler
- Pharmascience Inc.
- Active ingredients
- bortezomib
- Form
- INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
- Routes
- INTRAVENOUS, SUBCUTANEOUS
- Administrative status
- present-in-source-snapshot
- Marketing status
- ANDA
- Product type
- HUMAN PRESCRIPTION DRUG
- Prescription
- Prescription or restricted
Names this record is found by
Complete source data
{
"name": "Bortezomib",
"splId": "de0c8157-9e0e-4964-e053-2995a90a1259",
"labels": [
{
"setId": "191d231a-1fbd-4a65-9d33-d5dc03bac381",
"labelUrl": "https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=191d231a-1fbd-4a65-9d33-d5dc03bac381",
"labelPdfUrl": "https://dailymed.nlm.nih.gov/dailymed/downloadpdffile.cfm?setId=191d231a-1fbd-4a65-9d33-d5dc03bac381"
}
],
"routes": [
"INTRAVENOUS",
"SUBCUTANEOUS"
],
"labeler": "Pharmascience Inc.",
"finished": true,
"packaging": [
{
"sample": false,
"description": "1 VIAL in 1 CARTON (51817-586-01) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL",
"package_ndc": "51817-586-01",
"identifierStatus": "well-formed",
"marketing_start_date": "20220502"
}
],
"productId": "51817-586_de0c8157-9e0e-4964-e053-2995a90a1259",
"useDomain": "unknown",
"dosageForm": "INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION",
"productNdc": "51817-586",
"deaSchedule": null,
"genericName": "bortezomib",
"productType": "HUMAN PRESCRIPTION DRUG",
"listingStatus": "present-in-source-snapshot",
"targetSpecies": [],
"approvalStatus": "not-established-by-ndc-listing",
"labelAssociation": "openFDA-harmonized-set-ids; not a product-level approval match",
"marketingEndDate": null,
"activeIngredients": [
{
"name": "BORTEZOMIB",
"strength": "3.5 mg/1"
}
],
"applicationNumber": "ANDA208392",
"marketingCategory": "ANDA",
"stateRestrictions": {
"status": "not-collected",
"observations": []
},
"useDomainEvidence": {
"basis": "unreviewed",
"field": null,
"value": null,
"version": 1,
"sourceId": "us.fda.ndc"
},
"marketingStartDate": "20220502",
"targetSpeciesStatus": "not-reported",
"prescriptionCategory": "prescription-or-restricted",
"harmonizedIdentifiers": {
"nui": [
"N0000175604",
"N0000175075"
],
"unii": [
"69G8BD63PP"
],
"rxcui": [
"402243"
],
"spl_set_id": [
"191d231a-1fbd-4a65-9d33-d5dc03bac381"
],
"pharm_class_epc": [
"Proteasome Inhibitor [EPC]"
],
"pharm_class_moa": [
"Proteasome Inhibitors [MoA]"
],
"manufacturer_name": [
"Pharmascience Inc."
],
"is_original_packager": [
true
]
},
"listingExpirationDate": "20271231"
}
Read this record from your own software
The same record, with every field and its provenance, is one request away. An API key is free and works immediately.
curl -G "https://api.medifontis.com/v1/drugs/record" \
-H "Authorization: Bearer $MEDIFONTIS_API_KEY" \
--data-urlencode "country=us" \
--data-urlencode "sourceId=us.fda.ndc" \
--data-urlencode "id=us:fda:ndc:51817-586_de0c8157-9e0e-4964-e053-2995a90a1259"